Gastrointestinal (GI) complications have become increasingly common with the rising prevalence of diabetes. These complications include gastroparesis and enteropathy, which are primarily attributed to abnormal GI motility resulting from diabetic autonomic neuropathy affecting the GI tract. Up to 75% of individuals with diabetes may experience GI symptoms, significantly impacting their quality of life and increasing healthcare costs. The hallmark GI symptoms associated with diabetes include postprandial fullness, nausea, bloating, abdominal pain, diarrhea, and constipation.